Reuters logo
8 months ago
BRIEF-Juniper Pharmaceuticals prototype formulation development for JNP-0301 is underway
January 5, 2017 / 1:54 PM / 8 months ago

BRIEF-Juniper Pharmaceuticals prototype formulation development for JNP-0301 is underway

Jan 5 (Reuters) - Juniper Pharmaceuticals Inc :

* Prototype formulation development for jnp-0301 is underway, with ind-enabling studies planned for 2017

* Company expects to initiate definitive sheep studies by year-end 2017 for jnp-0301

* Juniper pharmaceuticals inc- sheep studies could potentially enable an ind submission in first half of 2018 for jnp-0301 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below